Chloroquine for Patients With Symptomatic Persistent Atrial Fibrillation: A Prospective Pilot Study
Status:
Unknown status
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
The goal of this pilot study is to explore the efficacy of chloroquine in terminating
persistent AF and assess its potential role as a pharmacological cardioversion agent for the
management of AF.